A Family Impacted by Compounding Pharmacy’s Tainted Medications Seeks to Transfer all Related Cases to A Minnesota Court |

By Catherine Bertram, partner

A family that filed a contaminated steroid case against New England Compounding Pharmacy asked the the Judicial Panel on Multidistrict Litigation to transfer all federal compounding pharmacy cases to the U.S. District of Minnesota for consolidated pretrial proceedings.

It is reported that attorneys for Brenda and Robert Bansale made this request in a filing earlier this week. They argue all the compounding pharmacy cases should be combined for motion practice, discovery and damage issues because it will involve the same evidence and arguments and therefore consolidation is appropriate under the federal code.

We are investigating several cases of tainted medication for families and our firm participates in these class actions, commonly referred to as MDLs (multi-district litigation) across the country for clients from various states. If you have questions about this litigation feel free to call me. 202-822-1875.

About the author:

Catherine Bertram is board certified in civil trials. She has been recognized as one of the Best Lawyers in DC for Medlcal Malpractice by Washingtonian Magazine, Best Lawyers and Super Lawyers. Ms. Bertram has over 20 years of trial experience and is unique in that she was formerly the Director of Risk Management for Georgetown University Hospital. Ms. Bertram is a member of the bar for the U.S. Supreme Court. Ms. Bertram is a partner with the firm and she lives in Washington, DC with her family She has also recently published a chapter on informed consent in a surgical textbook. She can be reached by email at cbertram@reganfirm.com or by phone 202-822-1875 in her office in Washington, D.C.